-
-
-
-
-
-
-
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
-
-
-
-
-
-
-
Protagonist Therapeutics (PTGX) PT Raised to $67 at BTIG
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/11: (PTGX) (ADMS) (FLXN) Higher; (HYLN) (LUV) (NET) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Movers 05/30: (PTGX) (ATW) (XTLY) Higher; (AMBA) (WLL) (BWLD) Lower (more...)
1,155,049 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

